Cart
sales@molnova.com
CD73-IN-1
CAS No. 2132396-40-6
CD73-IN-1( —— )
Catalog No. M32829 CAS No. 2132396-40-6
CD73-IN-1 is a CD73 inhibitor with anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 135 | In Stock |
|
| 5MG | 225 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCD73-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCD73-IN-1 is a CD73 inhibitor with anticancer activity.
-
DescriptionCD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCD73
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2132396-40-6
-
Formula Weight371.41
-
Molecular FormulaC18H17N3O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 150 mg/mL (403.87 mM)
-
SMILESNC(=O)c1cc(ccc1O)S(=O)(=O)Nc1ccc2cc([nH]c2c1)C1CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jerry Leroy Adams, et al. 5-sulfamoyl-2-hydroxybenzamide derivatives. WO 2017153952 A1.
molnova catalog
related products
-
ProTx III
Potent Nav1.7 blocker (IC50 = 2.5 nM). Also inhibits Nav1.1, Nav1.2, Nav1.3 and Nav1.6 in the nanomolar range. Exhibits no effects on Cav channels or nAChR at 5 μM. Demonstrates analgesic activity in vivo; antagonizes effects of scorpion-venom toxin OD1 at Nav1.7.
-
EZH2-IN-2
EZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity.
-
Teneligliptin hydrob...
Teneligliptin is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 values of approximately 1 nM.
